GlassScriptPhysician profile
James M Meek
NPI 1992706386
$2,673.83
in general payments reported to CMS, 2019-2025
30 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $61.85 · 2021: $73.31 · 2022: $1,023 · 2023: $534 · 2024: $320 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $539.92 | 2019-2024 | |
| Pfizer INC. | $306.51 | 2019-2024 | |
| Novo Nordisk INC | $189.72 | 2023-2025 | Wegovy |
| Aspira Women'S Health INC | $189.28 | 2022 | |
| Astellas Pharma US INC | $174.60 | 2022-2024 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $172.22 | 2022-2025 | |
| Channel Medsystems, INC. | $152.89 | 2022 | |
| Organon LLC | $131.07 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $89.62 | 2019-2023 | |
| Daiichi Sankyo INC. | $77.73 | 2019-2025 | Injectafer |
| Myovant Sciences INC. | $60.50 | 2022 | |
| Agile Therapeutics, INC. | $60.14 | 2022 | |
| Avion Pharmaceuticals | $58.87 | 2019 | |
| Mylan Pharmaceuticals INC. | $56.01 | 2019-2022 | |
| Exeltis, USA INC. | $45.02 | 2021-2023 | Slynd |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $39.79 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $36.79 | 2019-2020 | |
| Exact Sciences Corporation | $35.10 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $34.89 | 2021-2025 | Solosec, Phexx, Phexxi |
| Therapeuticsmd, INC. | $34.81 | 2019-2022 | |
| Welch Allyn | $32.95 | 2019 | |
| Scynexis, INC. | $24.57 | 2022 | |
| Allergan, INC. | $20.97 | 2019 | |
| Ethicon US, LLC | $19.11 | 2020 | |
| Shield Therapeutics INC | $18.81 | 2023 | Accrufer |
| Amag Pharmaceuticals, INC. | $17.64 | 2019 | |
| Hologic Sales and Service, LLC | $16.45 | 2022 | |
| Coopersurgical, INC. | $13.37 | 2023 | Endosee |
| Mission Pharmacal Company | $12.81 | 2019 | |
| Duchesnay USA Incorporated | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Meek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.